Improved Immunodetection of Endogenous α-Synuclein

被引:118
作者
Lee, Byung Rho [1 ]
Kamitani, Tetsu [1 ]
机构
[1] Georgia Hlth Sci Univ, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA
基金
美国国家卫生研究院;
关键词
PARKINSONS-DISEASE; MUTATION; PHOSPHORYLATION; MEMBRANE;
D O I
10.1371/journal.pone.0023939
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
alpha-Synuclein is a key molecule in understanding the pathogenesis of neurodegenerative alpha-synucleinopathies such as Parkinson's disease. Despite extensive research, however, its precise function remains unclear partly because of a difficulty in immunoblotting detection of endogenous alpha-synuclein. This difficulty has largely restricted the progress for alpha-synucleinopathy research. Here, we report that alpha-synuclein monomers tend to easily detach from blotted membranes, resulting in no or very poor detection. To prevent this detachment, a mild fixation of blotted membranes with paraformaldehyde was applied to the immunoblotting method. Amazingly, this fixation led to clear and strong detection of endogenous alpha-synuclein, which has been undetectable by a conventional immunoblotting method. Specifically, we were able to detect endogenous alpha-synuclein in various human cell lines, including SH-SY5Y, HEK293, HL60, HeLa, K562, A375, and Daoy, and a mouse cell line B16 as well as in several mouse tissues such as the spleen and kidney. Moreover, it should be noted that we could clearly detect endogenous alpha-synuclein phosphorylated at Ser-129 in several human cell lines. Thus, in some tissues and cultured cells, endogenous alpha-synuclein becomes easily detectable by simply fixing the blotted membranes. This improved immunoblotting method will allow us to detect previously undetectable endogenous alpha-synuclein, thereby facilitating alpha-synuclein research.
引用
收藏
页数:8
相关论文
共 16 条
[1]   Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease [J].
Anderson, John P. ;
Walker, Donald E. ;
Goldstein, Jason M. ;
de laat, Rian ;
Banducci, Kelly ;
Caccavello, Russell J. ;
Barbour, Robin ;
Huang, Jiping ;
Kling, Kristin ;
Lee, Michael ;
Diep, Linnea ;
Keim, Pamela S. ;
Shen, Xiaofeng ;
Chataway, Tim ;
Schlossmacher, Michael G. ;
Seubert, Peter ;
Schenk, Dale ;
Sinha, Sukanto ;
Gai, Wei Ping ;
Chilcote, Tamie J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) :29739-29752
[2]   α-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease [J].
Auluck, Pavan K. ;
Caraveo, Gabriela ;
Lindquist, Susan .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26, 2010, 26 :211-233
[3]   The role of α-synuclein in neurodegenerative diseases [J].
Bennett, MC .
PHARMACOLOGY & THERAPEUTICS, 2005, 105 (03) :311-331
[4]   α-Synuclein is phosphorylated in synucleinopathy lesions [J].
Fujiwara, H ;
Hasegawa, M ;
Dohmae, N ;
Kawashima, A ;
Masliah, E ;
Goldberg, MS ;
Shen, J ;
Takio, K ;
Iwatsubo, T .
NATURE CELL BIOLOGY, 2002, 4 (02) :160-164
[5]   Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein [J].
Jakes, R ;
Crowther, RA ;
Lee, VMY ;
Trojanowski, JQ ;
Iwatsubo, T ;
Goedert, M .
NEUROSCIENCE LETTERS, 1999, 269 (01) :13-16
[6]   Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease [J].
Krüger, R ;
Kuhn, W ;
Müller, T ;
Woitalla, D ;
Graeber, M ;
Kösel, S ;
Przuntek, H ;
Epplen, JT ;
Schöls, L ;
Riess, O .
NATURE GENETICS, 1998, 18 (02) :106-108
[7]  
LAURITZEN E, 1988, J ACQ IMMUN DEF SYND, V1, P333
[8]  
MAROTEAUX L, 1988, J NEUROSCI, V8, P2804
[9]   Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma [J].
Matsuo, Yasuhiro ;
Kamitani, Tetsu .
PLOS ONE, 2010, 5 (05)
[10]   Proteomics Analysis Identifies Phosphorylation-dependent α-Synuclein Protein Interactions [J].
McFarland, Melinda A. ;
Ellis, Christopher E. ;
Markey, Sanford P. ;
Nussbaum, Robert L. .
MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (11) :2123-2137